Medical Need

THERAPEUTIC PROCEDURES THAT REQUIRE
LARGE BORE VENOUS ACCESS CLOSURE

Current Trans-Venous Procedures

Current therapies that require large bore venous vascular access:

 

  • ASD Closure
  • Left Arterial Appendix Occluder
  • Mitral Valve Repair (currently only one technology available)
  • Vena Cava Filter
  • Atrial Ablation
  • Pulmonary Embolectomy
  • Venous Thrombectomy
     

These trans-venous therapies add up to approximately 5 million procedures per year in USA and Europe.

Upcoming Trans-Venous Procedures

A dramatic increase in interventional procedures that require large bore venous vascular access site is expected once novel technologies under development for structural heart treatment in development will mature.

  • Transcatheter Mitral Valve Repair
  • Transcatheter Mital Valve Prosthesis Implantation
  • Transcatheter Tricuspid Valve Repair
  • Transcatheter Tricuspid Valve Prosthesis Implantation
  • Intra-Atrial Shunt Therapy
  • Left Ventricle Restoration
  • Left Ventricle Volume Reduction
  • Right Ventricle Assist Devices

As soon as these procedures are fully developed and utilized, the market for large bore venous access closure is expected to grow to 30 million procedures per year in the USA and Europe.

As of today there exists no effective vascular closure device for large bore punctures of venous vessels in the clinical practice.

Solution

The Venock System

The Venock vascular closure device is a percutaneous hand held device for automated closure of a large bore puncture in the femoral vein following an interventional procedure. The device is inserted over the already positioned guidewire in the vein and the perforation is tightly sealed within 1-2 minutes procedure time.

Advantages of Venock Vascular Closure Device

Closure within 1-2 minutes

The current practice is to stop venous bleeding with half an hour manual pressure, followed by compression bandage and 6 hours immobilization.

Quick sealing of the vein puncture will allows for earlier patient mobilization.

Earlier discharge

The current practice is to keep patients overnight in the hospital, being immobilized and bedridden with a compression bandage and sand sack.

Quick sealing of the vein puncture will allow for earlier patient discharge.

Less complications

Sealing of the vein puncture by compression results in hematoma, pain and swelling. Patient immobilization increases the risk for vein thrombosis.

Reliable and quick sealing of vein puncture will reduce serious complications.

Cost savings

Quick sealing of the vein puncture will free up resources and more interventional procedures can be converted from inpatient to outpatient settings.

Consequently, the utilization of Venock Closure device is cost effective.

PROF. DR. HORST SIEVERT

Arterial closure devices have tremendously improved the post-interventional recovery process by saving time and resources, decreasing patient discomfort, and eliminating complications like hematoma. I am looking forward to seeing the same benefits in large bore venous closure.

The Venock device will attain large bore venous closure in under a minute, thus saving time and money, while significantly reducing patient discomfort and time to discharge when compared to the recovery from manual compression.

CARDIOLOGIST, INTENSIVIST
DIRECTOR OF CENTER FOR CARDIOLOGY, PERIPHERAL VASCULAR AND CEREBROVASCULAR DISEASE FRANKFURT, GERMANY

PROF. DR. CHRISTIAN HENGSTENBERG

Large bore venous closure has long been a drain on time and resources during many of my procedures. I am thrilled to hear that Venock is taking on this important task and am convinced their approach will produce a robust and effective device that is closing large bore venous punctures within minutes.

My patients tell me that their only negative memory after an interventional procedure is being bedridden with a compression bandage and suffering from a hematoma and considerable pain in their groin. I am eager to provide a solution which will end this pain.

CARDIOLOGIST
DIRECTOR UNIVERSITY HOSPITAL VIENNA, AUSTRIA

DR. SAMEER GAFOOR

Large-bore femoral venous access is becoming more commonplace, but access closure still often requires hours of postprocedural monitoring and bedrest.

I am happy to hear that Venock is developing a large bore venous closure that facilitate early hospital discharge for this fast-growing patient population.

 

CARDIOLOGIST
STRUCTURAL HEART DISEASE SWEDISH MEDICAL CENTER, SEATTLE, WA, USA

Our Management Team

Powered by People

Terry Barnes

CHIEF EXECUTIVE OFFICER

Learn more

Dipl.-Kfm. Marcus Irsfeld

CHIEF FINANCIAL OFFICER

Learn more

Dr. Wolfgang Goetz

FOUNDER & CHAIRMAN OF THE BOARD

Learn more

Our Achievements

News

First closing of Seed Investment Round

2019-03-01: Newly founded and privately held U.S. medical technology company Venock, Inc. announces first closing of seed financing.

Read more …

Contact

Get in Touch

HEAD QUARTER USA

VENOCK INC.

521 Fifth Avenue, Floor 17 | New York, NY 10175 | USA

OPERATIONS GERMANY

VENOCK MEDICAL GMBH

c/o WeWork | Neuturmstrasse 5 | 80331 München | Germany

MEETING US AT EVENTS

We plan to attend the following events and are looking forward to arranging a meeting with you.

 

Currently there are no events.

Are you interested in an investment or in a joint development?
Please contact us.

WIPANO Patentförderung

Förderprogramm WIPANO des Bundesministeriums für Wirtschaft und Energie

External link: http://www.wipano.de